Volume 13 Issue 3 - International Pharmaceutical Industry

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Volume 13 Issue 3

The Case for a Distributable CDx Model

The past decade has been an exciting era in healthcare for patients and providers with the increasingly broad adoption of precision medicine in drug development, cli...

13 September 2021 Volume 13 Issue 3 clinical trials | drug development

Continue Reading →

Volume 13 Issue 3

Beyond the Pill – Why Reliable Electronics is Key to Healthcare

Technology is a driving force in improving and enhancing healthcare, with advanced electronics integral to many medical developments. Today, medical improvements go ...

13 September 2021 Volume 13 Issue 3 electronics | healthcare

Continue Reading →

Volume 13 Issue 3

How Technology is Making an Impact in Improving Managed Access Programs

In the pharmaceutical industry, it’s critical to deliver medicine quickly to patients that need it most. Managed Access Programs have helped make new treatments more...

13 September 2021 Volume 13 Issue 3 CyberGrants | Managed Access Programs

Continue Reading →

Volume 13 Issue 3

Building Common Ground for Collective Intelligence:

How Digital Supply Networks Can Provide a New Era of Collaboration for Industry 4.0 In the pharma industry, new ground is gained every day in understanding how di...

13 September 2021 Volume 13 Issue 3 Collective Intelligence | digital supply networks

Continue Reading →

Volume 13 Issue 3

How to Future-Proof the Manufacture of Sterile Drug Products

The aseptic pharmaceutical processing market is growing incredibly quickly. This strong and sustained performance is being fuelled by greater demand for sterile drug...

13 September 2021 Volume 13 Issue 3 ChargePoint Technology | Manufacture

Continue Reading →

Volume 13 Issue 3

Formulation and Process Considerations for Optimising Spray-Dried Solid Dispersions

Spray drying active pharmaceutical ingredients (APIs) in solution to overcome solubility hurdles requires part craft and great attention to process variables. Today’...

13 September 2021 Volume 13 Issue 3 APIs | drug innovators

Continue Reading →

Volume 13 Issue 3

From R&D to Production: How the Bioreactor Choice Can Streamline Biologics Scale-Up

Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bio...

13 September 2021 Volume 13 Issue 3 biologic candidate | bioreactors

Continue Reading →

Volume 13 Issue 3

Small-Scale Batch Production for Clinical Gamma Scintigraphy Studies of Pharmaceuticals

Pharmaceutical gamma scintigraphy is a technique that has been adapted from clinical diagnostic applications to enable the in vivo fate of pharmaceutical dosage form...

13 September 2021 Volume 13 Issue 3 clinical gamma scintigraphy | drug delivery

Continue Reading →

Volume 13 Issue 3

New DPI Data Insights Shaping Future of Global Healthcare Needs

Innovative inhalation therapies and drug delivery are legacies of the COVID-19 pandemic, as pharma and biopharma formulators address growing demands for new healthca...

13 September 2021 Volume 13 Issue 3 asthma | COPD

Continue Reading →

Volume 13 Issue 3

Aseptic Processing and Cleanroom Technology

The cleanroom technology market is a growing segment of the manufacturing industry that is expected to expand from a value of $3.87bn in 2019 to $5.04bn by 2025. One...

13 September 2021 Volume 13 Issue 3 Aseptic Processing | cleanroom technology

Continue Reading →